Patents by Inventor Patrick D. Moss

Patrick D. Moss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100111961
    Abstract: In one aspect, the present invention provides isolated nucleic acid molecules that encode a CAN-1 polypeptide, or an STG polypeptide. In another aspect, the present invention also provides isolated STG polypeptides, isolated CAN-1 polypeptides, and isolated SEEK-1 polypeptides. In another aspect, the present invention provides isolated antibodies that bind specifically to a CAN-1, SEEK-1 or STG polypeptide. In another aspect, the present invention provides methods of diagnosing or predicting the susceptibility to psoriasis of an individual. In another aspect, the present invention provides methods for ameliorating the symptoms and/or progression of psoriasis.
    Type: Application
    Filed: October 13, 2009
    Publication date: May 6, 2010
    Applicant: CELLTECH R & D, INC.
    Inventors: PATRICK R. CHARMLEY, PATRICK D. MOSS, MARK D. MCEUEN
  • Patent number: 7622278
    Abstract: In one aspect, the present invention provides isolated nucleic acid molecules that encode a CAN-1 polypeptide, or an STG polypeptide. In another aspect, the present invention also provides isolated STG polypeptides, isolated CAN-1 polypeptides, and isolated SEEK-1 polypeptides. In another aspect, the present invention provides isolated antibodies that bind specifically to a CAN-1, SEEK-1 or STG polypeptide. In another aspect, the present invention provides methods of diagnosing or predicting the susceptibility to psoriasis of an individual. In another aspect, the present invention provides methods for ameliorating the symptoms and/or progression of psoriasis.
    Type: Grant
    Filed: July 9, 2008
    Date of Patent: November 24, 2009
    Assignee: UCB SA
    Inventors: Patrick R. Charmley, Patrick D. Moss, Mark D. McEuen
  • Publication number: 20090087439
    Abstract: In one aspect, the present invention provides isolated nucleic acid molecules that encode a CAN-1 polypeptide, or an STG polypeptide. In another aspect, the present invention also provides isolated STG polypeptides, isolated CAN-1 polypeptides, and isolated SEEK-1 polypeptides. In another aspect, the present invention provides isolated antibodies that bind specifically to a CAN-1, SEEK-1 or STG polypeptide. In another aspect, the present invention provides methods of diagnosing or predicting the susceptibility to psoriasis of an individual. In another aspect, the present invention provides methods for ameliorating the symptoms and/or progression of psoriasis.
    Type: Application
    Filed: July 9, 2008
    Publication date: April 2, 2009
    Applicant: UCB SA
    Inventors: Patrick R. Charmley, Patrick D. Moss, Mark D. McEuen
  • Patent number: 6989247
    Abstract: In one aspect, the present invention provides isolated nucleic acid molecules that encode a CAN-1 polypeptide, or an STG polypeptide. In another aspect, the present invention also provides isolated STG polypeptides, isolated CAN-1 polypeptides, and isolated SEEK-1 polypeptides. In another aspect, the present invention provides isolated antibodies that bind specifically to a CAN-1, SEEK-1 or STG polypeptide. In another aspect, the present invention provides methods of diagnosing or predicting the susceptibility to psoriasis of an individual. In another aspect, the present invention provides methods for ameliorating the symptoms and/or progression of psoriasis.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: January 24, 2006
    Assignee: Celltech R & D, Inc.
    Inventors: Patrick R. Charmley, Patrick D. Moss, Mark D. McEuen
  • Publication number: 20020115148
    Abstract: In one aspect, the present invention provides isolated nucleic acid molecules that encode a CAN-1 polypeptide, or an STG polypeptide. In another aspect, the present invention also provides isolated STG polypeptides, isolated CAN-1 polypeptides, and isolated SEEK-1 polypeptides. In another aspect, the present invention provides isolated antibodies that bind specifically to a CAN-1, SEEK-1 or STG polypeptide. In another aspect, the present invention provides methods of diagnosing or predicting the susceptibility to psoriasis of an individual. In another aspect, the present invention provides methods for ameliorating the symptoms and/or progression of psoriasis.
    Type: Application
    Filed: November 26, 2001
    Publication date: August 22, 2002
    Applicant: Celltech R & D, Inc.
    Inventors: Patrick R. Charmley, Patrick D. Moss, Mark D. McEuen